Advertisement

 

 

Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma.

Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma.
Author Information (click to view)

Leopold SA, Zeilbeck LF, Weber G, Seitz R, Bösl MR, Jägle H, Fuchshofer R, Tamm ER, Ohlmann A,


Leopold SA, Zeilbeck LF, Weber G, Seitz R, Bösl MR, Jägle H, Fuchshofer R, Tamm ER, Ohlmann A, (click to view)

Leopold SA, Zeilbeck LF, Weber G, Seitz R, Bösl MR, Jägle H, Fuchshofer R, Tamm ER, Ohlmann A,

Advertisement

Scientific reports 2017 10 277(1) 14274 doi 10.1038/s41598-017-14423-8
Abstract

Norrin is a secreted signaling molecule activating the Wnt/β-catenin pathway. Since Norrin protects retinal neurons from experimental acute injury, we were interested to learn if Norrin attenuates chronic damage of retinal ganglion cells (RGC) and their axons in a mouse model of glaucoma. Transgenic mice overexpressing Norrin in the retina (Pax6-Norrin) were generated and crossed with DBA/2J mice with hereditary glaucoma and optic nerve axonal degeneration. One-year old DBA/2J/Pax6-Norrin animals had significantly more surviving optic nerve axons than their DBA/2J littermates. The protective effect correlated with an increase in insulin-like growth factor (IGF)-1 mRNA and an enhanced Akt phosphorylation in DBA/2J/Pax6-Norrin mice. Both mouse strains developed an increase in intraocular pressure during the second half of the first year and marked degenerative changes in chamber angle, ciliary body and iris structure. The degenerations were slightly attenuated in the chamber angle of DBA/2J/Pax6-Norrin mice, which showed a β-catenin increase in the trabecular meshwork. We conclude that high levels of Norrin and the subsequent constitutive activation of Wnt/β-catenin signaling in RGC protect from glaucomatous axonal damage via IGF-1 causing increased activity of PI3K-Akt signaling. Our results identify components of a protective signaling network preventing degeneration of optic nerve axons in glaucoma.

Submit a Comment

Your email address will not be published. Required fields are marked *

4 × 3 =

[ HIDE/SHOW ]